Table 2.
CO-containing systems for antibacterial therapy.
| Gas donor | System | Combined therapy or treatment | Other materials | Ref. |
|---|---|---|---|---|
| CORM-2 | CORM-2 | – | – | [[180], [181], [187], [188], [190], [191]] |
| CORM-2 | CORM-2 | Metronidazole, clarithromycin, and amoxicillin | – | [189] |
| CORM-2 | CORM-2-conjugated polymer | – | Thiodiblock copolymer | [192] |
| CORM-2 | P(METMA-b-PEGMA-CORM) | METMA-b-PEGMA | [193] | |
| CORM-3 | CORM-3 | – | – | [[180], [181], [194], [195], [196], [197]] |
| [Mn(CO)3(tpa-κ3N)]Br | [Mn(CO)3(tpa-κ3N)]Br | – | – | [[198], [199], [200]] |
| Trypto-CORM | Trypto-CORM | – | – | [202] |
| Mn2(CO)10 | Mn2(CO)10-embedded electrospun nonwoven | – | Poly(l-lactide-co-dl-lactide) nonwoven | [203] |
| fac-[Mn(CO)3(BZM)Br] and [RuCl2(BZM)(CO)2] | fac-[Mn(CO)3(BZM)Br] and [RuCl2(BZM)(CO)2] | – | – | [204] |
| 3-Hydroxy-2-phenyl-4H-benzo[h]chromen-4-one | CORM-Ac | – | Acetic anhydride | [182] |
| CORM-401 | Ce6&CO@FADP | PDT | Ce6 and FADP | [183] |
| Reaction between 1O2 and 3-HF | TPP-HF micelle | PDT | TPP | [205] |
| POS NS and the reduction of CO2 | POS-UCNPs/ICG | PDT | UCNP and ICG | [206] |
| Fe3(CO)12 | DNase–CO@MPDA | PTT | DNase I and MPDA | [207] |
Abbreviations: Ce6: chlorin e6; DNase I: deoxyribonuclease I; FADP: fluorinated amphiphilic dendritic peptide; 3-HF: 3-hydroxyflavone; ICG: indocyanine green; METMA: methionine methacryloyloxyethyl ester; MPDA: mesoporous poly dopamine; PDT: photodynamic therapy; PEGMA: poly(ethylene glycol methyl ether methacrylate); POS NS: partially oxidized tin disulfide nanosheet; PTT: photothermal therapy; TPP: tetraphenylporphyrin; UCNP: upconversion nanoparticle.